Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Taosu Biochemical Technology was a Shanghai-based life science tools and drug discovery services company focused on small-molecule compound supply, compound libraries, virtual screening, target-based screening, custom synthesis, and related preclinical research services. The company marketed products and services under the TOPSCIENCE brand and was associated with the broader Taosu/TargetMol business serving researchers in China and overseas. Its offerings included inhibitor products, screening libraries, molecular docking and kinase profiling support, lead discovery support, and cell or animal experiment services for early drug discovery. Available public sources indicate the legal entity was founded in 2011 and was deregistered in 2023, although the broader Taosu/TargetMol commercial brand and website appear to remain active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Taosu Biochemical Technology.